ADAA is pleased to make available up to 30 CE and CME credits to registered professional physicians, psychologists, social workers, and counselors.
Continuing education credits are for professional attendees only; those paying student, trainee/postdoctoral fellow/resident, guest, or consumer fees cannot apply for CE or CME credits. All registrants who want credits must complete the continuing education form on-site and return the evaluation form by the deadline.
Social Workers, Certified Counselors, Marriage and Family Therapists
Physicians assistants and nurse practitioners – AMA PRA Category 1 Credit can only be awarded to MDs or DOs (or physicians with equivalent degrees from other countries). Nonphysicians may not be awarded AMA PRA Category 1 Credit. Nonphysicians may, however, receive a certificate of attendance/participation that acknowledges the activity was designated for AMA PRA Category 1 Credit in order to apply their participation toward relicensure.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Blackwell Futura Media Service and Anxiety Disorders Association of America (ADAA). Blackwell Futura Media Service is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 CreditTM. Blackwell Futura Media Service and ADAA present this activity for educational purposes only and do not endorse any product, content of presentation, or exhibit. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected because of their recognized expertise.
It is the policy of Blackwell Futura Media Service to plan and implement all of its educational activities in accordance with the ACCME’s Essential Areas and Policies to ensure balance, independence, objectivity, and scientific rigor. In accordance with the ACCME’s Standards for Commercial Support, everyone who is in a position to control the content of an educational activity certified for AMA PRA Category 1 CreditTM is required to disclose all financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Individuals who do not disclose are disqualified from participating in a CME activity. Individuals with potential for influence or control of CME content include planners and planning committee members, authors, teachers, educational activity directors, educational partners, and others who participate, eg, facilitators and moderators. This disclosure pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be resolved prior to the educational activity. Disclosure of off-label, experimental, or investigational use of drugs or devices must also be made known to the audience.
As a provider of continuing education credits, ADAA complies with all policies and guidelines from the AACME, American Psychological Association, National Association of Social Workers, and National Board of Certified Counselors. All sessions at the ADAA conference offer CME and CE credit except the New Research Poster Sessions. The AACME has clarified that employees of commercial interests (pharmaceutical, biotech, and medical-device companies) cannot participate as presenters, moderators, abstract authors (whether presenting or not), or in other roles that influence content for a session that is certified for CME credit. Authors employed by commercial interests can submit an abstract for a New Research Poster Session and present it if accepted following peer review.
All presenters must complete conflict of interest and disclosure statements even if you have nothing to disclose.
This activity is being planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Blackwell Futura Media Services and the Anxiety and Depression Association of America. Blackwell Futura Media Services is accredited by the ACCME to provide continuing medical education for physicians.
To qualify the conference for continuing medical education (CME) credit for physicians in attendance, ADAA must comply with policies set forth by the Accreditation Council for Continuing Medical Education (ACCME). All presenters and authors (including non-presenting authors of oral submissions) must complete online disclosure and conflict of interest forms. All CME providers are required to implement mechanisms to identify and resolve any conflicts of interest prior to the education activity being delivered to learners. Any presenter who has a commercial interest and is presenting material related to it is considered to have a conflict of interest and is subject to restrictions.
The annual conference of the Anxiety and Depression Association of America (ADAA) is designed to meet the educational needs of member and nonmember clinicians and researchers by providing training, dissemination of evidence-based treatments, and translation of the latest research.
Anxiety disorders and depression are common and disabling. Anxiety disorders comprise a diagnostic category that includes generalized anxiety disorder, panic disorder, obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), social anxiety disorder, and phobias. Lifetime prevalence estimates for all anxiety disorders and major depression are 28.8 percent and 16.6 percent, respectively. Mental illnesses account for more than half as many disability days as all physical illnesses, with anxiety and depressive disorders being the major causes of disability. More than 40 million adults have one or more anxiety disorder, and 19 million adults have depression; anxiety disorders are the most common mental illnesses in children.
Research has long documented the high comorbidity between anxiety disorders and depression; the latest data continues to highlight the importance of understanding the overlap between these disorders, not only with respect to their etiology, but also in terms of treatment course. In 50 percent of diagnoses, individuals have comorbid anxiety and depression. Additionally, anxiety and depression are the primary illnesses associated with suicide. To continue leading the field, ADAA has broadened its mission and vision to encompass anxiety and depressive disorders.
The desired results for the conference are that attendees are aware of the latest developments in preclinical and clinical research, are able to translate this knowledge to clinical practice, apply evidence-based research to practice, discuss real-world clinical experiences to influence research, and develop new skills and techniques to improve diagnosis, prevention, and treatment of anxiety and depressive disorders. It is also expected that researchers and clinicians will discuss how specific diagnoses manifest in the clinic and the reality of implementation of evidence-based and novel treatments in real world settings. Additionally, participants will evaluate and discuss how to use new technologies and social media in research and clinical practice, thus advancing the dissemination and implementation of empirically based and novel treatments.
Attendees are professionals, trainees, residents, and students committed to the diagnosis, treatment, prevention, and cure of anxiety disorders, including OCD and PTSD, depression, and stress-related disorders in children and adults. The audience includes physicians, psychologists, social workers, therapists, counselors, nurses, clinical researchers, and basic neuroscientists from the United States and other countries. Attendees include ADAA members and nonmembers. ADAA anticipates attendance of more than one thousand clinicians, researchers, students, trainees, postdoctoral fellows, and residents.
After participating in the 2014 annual conference, attendees should be able to:
• Recognize advances in diagnosis and treatments for anxiety, depression, and related disorders.
• Improve patient outcomes through the dissemination of evidence-based research and application to real-world clinical settings.
• Identify the etiology, pathophysiology, and neural pathways of anxiety and depressive disorders.
• Apply psycho- and pharmacotherapy interventions alone and in combination to develop treatment plans, predict treatment response, optimize remission, and prevent relapse.
• Discuss and innovate research on anxiety, depression, and related disorders.